HOPE ON THE HORIZON : EXPLORING CUTTING-EDGE MUSCULAR DYSTROPHY TREATMENTS

For years, muscular dystrophy (MD) has presented a daunting challenge to patients and families worldwide. However, recent advances in research offer a beacon of hope for the future. Scientists are tirelessly working on revolutionary treatments that aim to not only manage symptoms but also to slow down the progression of this debilitating disease.

In keeping with two current scientific studies by Shahim et al., [66,sixty seven] neurofilament mild (NfL) is a helpful biomarker of axonal injury that's been evaluated in TBI. In the very first examine [66], two teams of individuals with TBI have been recruited: a bunch of Swedish hockey gamers with lumbar puncture following sports-relevant TBI, a